4
Changes in Ownership
Phreesia, Inc. Filed Acc 0001127602-25-004226
SVP, Life Sciences sold 300 shares at $29.52 ($8,857)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Linetsky David SVP, Life Sciences | 2025-02-07 | Sale 10b5-1 | −300 | $29.52 | $8,857 | 229,751 | D: show line 1 in the form |
| Open-market sales · 300 sh · avg $29.52 · $8,857 | |||||||
Loading xslF345X05/form4.xml…